HenryJKaminskiMD

PubMed

• Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey.
  Macaluso, M., Rothenberg, M., Kuhnell, P., , Ferkol, T., Kaminski, H., Kimberlin, D., Benatar, M., Chehade, M.> ;JMIR Public Health and Surveillance. 2024 Feb 14
• Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
  James F Howard Jr, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma, John Hinton, Yessar Hussain, Raul Juntas-Morales, Henry J K...> ;Therapeutic Advances in Neurological Disorders. 2024 Jan 1
• Eye Segmentation Method for Telehealth: Application to the Myasthenia Gravis Physical Examination.
  Quentin Lesport, Guillaume Joerger, Henry J Kaminski, Helen Girma, Sienna McNett, Mohammad Abu-Rub, Marc Garbey> ;Sensors. 2023 Sep 7
• Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO.
  Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J Kaminski, Ali A Habib> ;Neurology and Therapy. 2023 Oct 1
• Attitudes and Beliefs Toward Thymectomy in the Myasthenia Gravis Patient Registry.
  Ali G Hamedani, Tarrant O McPherson, Inmaculada Aban, Ikjae Lee, Mark J Kupersmith, Gil I Wolfe, Henry J Kaminski> ;Journal of Clinical Neuromuscular Disease. 2023 Jun 1
• 4 citations
  Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO.
  Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J Kaminski, Ali A Habib> ;Neurology and Therapy. 2023 Oct 1
• 21 citations
  Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
  Liow, K. K., Howard, J., Bresch, S., Genge, A., Hewamadduma, C., Hinton, J., Hussain, Y., Juntas-Morales, R., Kaminski, H., Maniaol, A., Mantegazza, R., Masuda, M., Si...> ;The Lancet. Neurology. 2023 May 1
• 22 citations
  Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
  Vera Bril, Artur Drużdż, Julian Grosskreutz, Ali A Habib, Renato Mantegazza, Sabrina Sacconi, Kimiaki Utsugisawa, John Vissing, Tuan Vu, Marion Boehnlein, Ali Bozorg, ...> ;The Lancet. Neurology. 2023 May 1
• 1 citations
  A Rare Case of Metaplastic Thymoma Presenting With Myasthenia Gravis.
  Ilianne Vega Prado, John Shymansky, Anisha Apte, Keith Mortman, Henry J Kaminski, Stephanie Barak> ;International Journal of Surgical Pathology. 2024 Feb 1
• Serum metabolomics of treatment response in myasthenia gravis.
  Patricia Sikorski, Yaoxiang Li, Mehar Cheema, Gil I Wolfe, Linda L Kusner, Inmaculada Aban, Henry J Kaminski> ;Plos One. 2023 Jan 1
• 1 citations
  A Digital Telehealth System to Compute the Myasthenia Gravis Core Examination Metrics.
  Marc Garbey, Guillaume Joerger, Quentin Lesport, Helen Girma, Sienna McNett, Mohammad Abu-Rub, Henry Kaminski> ;JMIR Neurotechnology. 2023 Jan 1
• 4 citations
  The best and worst of times in therapy development for myasthenia gravis.
  Michael Benatar, Gary Cutter, Henry J Kaminski> ;Muscle & Nerve. 2023 Jan 1
• 2 citations
  Impact of the Covid-19 epidemic on a US sample of patients with myasthenia gravis.
  Gloria Gutierrez, Helen Girma, Pierce Kuhnell, Maurizio Macaluso, Henry J Kaminski> ;Therapeutic Advances in Rare Disease. 2022 Mar 10
• 30 citations
  Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders.
  Jan Jgm Verschuuren, Jacqueline Palace, Hiroyuki Murai, Martijn R Tannemaat, Henry J Kaminski, Vera Bril> ;The Lancet. Neurology. 2022 Feb 1
• 35 citations
  Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
  Ruth Chia, Sara Saez-Atienzar, Natalie Murphy, Adriano Chiò, Cornelis Blauwendraat, , Ricardo H Roda, Pentti J Tienari, Henry J Kaminski, Roberta Ricciardi, Melania Gu...> ;Proceedings of the National Academy of Sciences of the United States of America. 2022 Feb 1
• 8 citations
  Corticosteroid Treatment-Resistance in Myasthenia Gravis.
  Henry J Kaminski, Jordan Denk> ;Frontiers in Neurology. 2022 Jan 1
• 6 citations
  Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease.
  Sophie Cleanthous, Ann-Christin Mork, Antoine Regnault, Stefan J. Cano, Henry J. Kaminski, Thomas Morel> ;Orphanet Journal of Rare Diseases. 2021 Oct 30
• 14 citations
  Telemedicine visits in myasthenia gravis: expert guidance and the myasthenia gravis core exam (MG-CE).
  Amanda C. Guidon, Srikanth Muppidi, Richard Nowak, Jeffrey T. Guptill, Michael K. Hehir, Katherine Ruzhansky, Leeann B Burton, David Post, Gary Cutter, Robin Conwit, N...> ;Muscle & Nerve. 2021 May 6
• 2 citations
  Reduced plasmablast frequency is associated with seronegative myasthenia gravis.
  Jeffrey T. Guptill, Richard Barfield, Cliburn Chan, Melissa A. Russo, Doug Emmett, Shruti M. Raja, Janice M. Massey, Vern C. Juel, Lisa D. Hobson-Webb, Karissa L. Gabl...> ;Muscle & Nerve. 2020 Dec 24
• 70 citations
  COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).
  Srikanth Muppidi, Jeffrey T. Guptill, Saiju Jacob, Yingkai Li, Maria Elena Farrugia, Amanda C. Guidon, Jinny Tavee, Henry J. Kaminski, James F. Howard, Gary Cutter, He...> ;The Lancet. Neurology. 2020 Dec 1
• 28 citations
  Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis.
  Kenneth B. Hoehn, Casey S. Lee, Minh C. Pham, Robert J. Homer, Frank C. Detterbeck, Inmaculada Aban, Leslie Jacobson, Angela Vincent, Richard Nowak, Henry J. Kaminski,...> ;Proceedings of the National Academy of Sciences of the United States of America. 2020 Nov 16
• 15 citations
  Monoclonal Antibody-Based Therapies for Myasthenia Gravis.
  Sawsan Alabbad, Mohanad AlGaeed, Patricia Sikorski, Henry J. Kaminski> ;Biodrugs. 2020 Oct 1
• 9 citations
  Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.
  Joshua D. Green, Richard J. Barohn, Emanuela Bartoccion, Michael Benatar, Derrick Blackmore, Vinay Chaudhry, Manisha Chopra, Andrea M. Corse, Mazen M. Dimachkie, Ameli...> ;BMJ Open. 2020 Sep 18
• 23 citations
  Gender differences in quality of life among patients with myasthenia gravis in China
  Dong Dong, Marc K. C. Chong, Yushan Wu, Henry J. Kaminski, Gary Cutter, Xianhao Xu, Hai-Feng Li, Chongbo Zhao, Jian Yin, Siyue Yu, Jianfeng Zhu> ;Health and Quality of Life Outcomes. 2020 Sep 3
• 2 citations
  The presence of survivin on B cells from myasthenia gravis patients and the potential of an antibody to a modified survivin peptide to alleviate weakness in an animal ...
  Xiangyang Zhang, Michael J. Ciesielski, Robert A. Fenstermaker, Henry J. Kaminski, Linda L. Kusner> ;Journal of Immunology. 2020 Oct 1
• Join now to see all

Journal Articles

• Randomized Trial of Thymectomy in Myasthenia Gravis  
  Wolfe GI, Kaminski HJ, et. al., New Engl J Med, 8/11/2016
• Letter to the Editor  
  Wolfe GI, Kaminski HJ, Cutter GR, N Engl J Med, 1/1/2016
• Plasma IL-17 levels stratify across myasthenia gravis patient subtypes  
  Xie Y, Li H-F, Jiang B, Li Y, Kaminski HJ, Kusner LL, Exp Neurol, 1/1/2016
• Editorial from concerned physicians: Unintended effect of the orphan drug act on the cost of 3'4-diaminopyridine  
  Burns TM, Smith G, ….Kaminski HJ…Barohn R, Hehir M, Cytokines, 1/1/2016
• Analysis of a national surgical database for myasthenia gravis patients undergoing thymectomy  
  Alshaikh JT, Amdur R, Sidawy A, Trachiotis G, Kaminski HJ, Muscle Nerve, 1/1/2016
• GR gene polymorphism is associated with inter-subject variability in response to glucocorticoids in patients with myasthenia gravis  
  Xie Y, Meng Y, Li H-F, Hong Y, Zhu X, Sun L, Yue Y-X, Gao X, Li Y, Wang S, Kusner LL, Kaminski HJ, Europ J Neurol, 1/1/2016
• Seronegative myasthenia: A vanishing disorder?  
  Kaminski HJ, JAMA Neurol, 1/1/2016
• Randomized Trial of Thymectomy for Myasthenia Gravis  
  Wolfe GI, Kaminski HJ, Inmaculada B. Aban IB, Minisman G. Hui-Chien Kuo H-C., …. Vincent A, Dias-Tosta E, Robin Conwit R, Odenkirchen J, Marx A, Sonett, JR, Jaretzki A..., New Engl J Med, 1/1/2016
• Differential RNA profile induced by experimental autoimmune myasthenia gravis in rats  
  Kaminski HJ, Himuro K, Alshaikh J, Gong B, Cheng G, Kusner L, Front Physiol, 1/1/2016
• A genome wide association study of myasthenia gravis  
  Renton AE, Pliner HA, Provenzano C, Evoli A…Kaminski HJ…Drachman DB, Traynor BJ, JAMA Neurol, 1/1/2015
• How clinical trials of myasthenia gravis can inform preclinical drug development  
  Punga AR, Kaminski HJ, Richman DP, Benatar M, Exp Neurol, 1/1/2015
• Special issue on standardization of preclinical evaluation of animal models for myasthenia gravis  
  Kusner LL, Kaminski HJ, Exp Neurol, 1/1/2015
• Targeting therapy to the neuromuscular junction: A proof of concept  
  Kusner LL, Satija N, Cheng G, Kaminski HJ, Muscle Nerve, 1/1/2014
• Pitx2, an atrial fibrillation predisposition gene, stabilizes the postnatal intercalated disc  
  Tao Y, Zhang M, Li L, Bai Y, Zhou Y, Moon A, Kaminski HJ, Martin JF, Circulation: Cardiovascular Genetics, 1/1/2014
• The neuromuscular junction as Achilles' heel: Yet another autoantibody?  
  Drachman D, Kaminski HJ, Neurology, 1/1/2014
• RNA expression analysis supports extraocular muscle as a unique immunological environment  
  Zhou Y, Kaminski HJ, Gong B, Cheng G, Feuerman JM, Kusner LL, Invest Ophthalmol Vis Sci, 1/1/2014
• Survivin as a therapeutic target for antibody-mediated autoimmunity  
  Kusner LL, Marx A, Kaminski HJ, Fenstermaker RA, Ciesielski MJ, PLOS ONE, 1/1/2014
• Myeloid derived suppressor cells as therapy for experimental myasthenia gravis  
  Li Y, Tu Z, Quin S, Fung J, Kusner L, Kaminski HJ, Lu L, Lin F, J Immunol, 1/1/2014
• Metabolomic response to corticosteroid treatment among patients with myasthenia gravis  
  Sengupta M, Cheema A, Kaminski HJ, Kusner LL, PLOS ONE, 1/1/2014
• Neurologist workforce analysis: Estimating and forecasting supply and demand  
  Dall TM, Storm MV, Chakrabarti R, Drogan O, Keran C, Donofrio P, Henderson V, Kaminski HJ, Stevens J, Vidic T, Neurology, 1/1/2013
• The importance and hurdles to drug discovery for neurological disease  
  Berger, JR, Choi D, Kaminski HJ, Gordon MF, Hurko O, D'Cruz O, Pleasure S, Feldman E, Ann Neurol, 1/1/2013
• Genomic profiling reveals Pitx2 controls expression of mature extraocular muscle contraction-related genes  
  Zhou Y, Gong B, Kaminski HJ, Invest Ophthalmol Vis Sci, 1/1/2012
• Protective effect of scFv-Daf fusion protein on the complement attack to acetylcholine receptor A possible option for treatment of myasthenia gravis  
  Song C, Miao J, Xu J, Wu X, Zhang F, Wang X, Lin J, Li H, Li Z, Xu Z, Kaminski HJ, Muscle Nerve, 1/1/2012
• Recommendations for myasthenia gravis clinical trial  
  Benatar M, Sanders DB, Berry D, Cutter GC, Guptill J, Kaminski HJ, Mantegazza R, Meriggioli M, Quan J, Wolfe G, Muscle Nerve, 1/1/2012
• Mexiletine for treatment of myotonia: A triumph for rare disease networks  
  Hoffman E, Kaminski HJ, JAMA, 1/1/2012
• Join now to see all

Books/Book Chapters

• Nova Scientific Publishers 
  Chapter: Clinical Trials of Myasthenia Gravis. 
  Mineo TCNova Scientific Publishers, Hauppauge, NY2015
• Neurobiology of Brain Disorders 
  Chapter: Myasthenia Gravis. 
  Zigmond MJ, Coyle JT. Rowland LPElsevier, Amsterdam, Netherlands2014
• Neurobiology of Brain Disorders 
  Chapter: Introduction to Disorders of the Peripheral Nervous System. 
  Zigmond MJ, Coyle JT, Rowland LPElsevier, Amsterdam, Netherlands2014
• Neuromuscular Disease in Clinical Practice 
  Chapter: Myasthenia Gravis 
  Katirji B, Kaminski HJ, Ruff RLSpringer Publishing, New York, NY2013
• Neuromuscular Disease in Clinical Practice 
  Chapter: Autoantibody Testing of Autoimmune Neuromuscular Junction 
  Katirji B, Kaminski HJ, Ruff RLSpringer Publishing, New York, NY2013
• Neuromuscular Disease in Clinical Practice 
  Chapter: Rhabdomyolysis and Myoglobinuria. 
  Katirji B, Kaminski HJ, Ruff RLSpringer Publishing, New York, NY2013
• The Myasthenic Syndromes 
  Chapter: The natural history of myasthenia gravis. 
  Engel AGOxford University Press, New York, NY2012
• Autoimmune Disorders/Book 2 
  Chapter: Ocular myasthenia: Analysis of diagnostic and treatment options. 
  Huang F-PIntech Open Access Publisher, Rijeck, Croatia2011
• Myasthenia Gravis: Disease Mechanisms and Immune Intervention. 
  Chapter: Ocular myasthenia: Diagnosis, treatment, and pathogenesis. 
  Christadoss PLinus Publications, Deer Park, NY2010
• Myasthenia Gravis: Disease Mechanisms and Immune Intervention. 
  Chapter: Myasthenia gravis: The influence of complement and its regulatory proteins. 
  Christadoss PLinus Publications, Deer Park, NY2010
• Advances in Understanding Mechanisms and Treatment of Infantile Forms of Nystagmus 
  Chapter: The complement hypothesis to explain preferential involvement of extraocular muscle by myasthenia gravis. 
  Kaminski HJ, Zhou Y, Soltys J, Kusner LEditors: Leigh RJ, Devereaux M.Oxford University Press2008
• Myology 
  Chapter: Endocrine myopathies (Hyper- and hypofunctioning of adrenal, thyroid, pituitary, and parathyroid glands and iatrogenic steroid myopathy) 
  Ubogu E, Kaminski HJ, Ruff RLEditors: Engel AG, Banker BQ.McGraw-Hill Book Co., New York, NY2004
• Myasthenia Gravis and Related Disorders 
  Chapter: Treatment of Myasthenia Gravis. 
  Kaminski HJEditors: Kaminski HJ.Humana Press, Totowa, NJ2003
• The NORD Guide to Rare Disorders 
  Chapter: Myasthenia Gravis. 
  Kaminski HJLippincott, Williams & Wilkins, Philadelphia, PA2003
• Neuromuscular Disease in Clinical Practice 
  Chapter: Laboratory testing of autoimmune neuromuscular junction, hyperexcitability, and muscle disorders. 
  Mygland A, Santillan C, Kaminski HJEditors: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE.Butterworth Heinemann, Boston, MA2002
• Neuromuscular Disease in Clinical Practice 
  Chapter: Myopathies caused by endocrine and electrolyte disturbances. 
  Al-Shekhlee A, Ruff RL, Kaminski HJEditors: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE.Butterworth Heinemann, Boston, MA2002
• Neuromuscular Disease in Clinical Practice 
  Chapter: Myasthenia gravis. 
  Kaminski HJEditors: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE.Butterworth Heinemann, Boston, MA2002
• Disorders of Voluntary Muscle 
  Chapter: Drug-induced and iatrogenic myopathies. 
  Argov Z, Kaminski HJ, Al-Mudallal A, Ruff RLEditors: Hilton-Jones D, Griggs RC, Karpati G.Cambridge University Press2001
• Handbook of Differential Diagnosis in Neurology 
  Chapter: Muscle and neuromuscular junction diseases. 
  Boonyapisit K, Kaminski HJEditors: Poolos N.Butterworth Heinemann2001
• The Myasthenic Syndromes 
  Chapter: Structure and kinetic properties of the acetylcholine receptor. 
  Kaminski HJ, Ruff RLEditors: Engel AG.Oxford University Press, New York, NY1999
• Muscle Diseases 
  Chapter: Endocrine and toxic myopathies. 
  Zaidat O, Kaminski HJ, Ruff RLEditors: Schapira AHV, Griggs RC.Butterworth-Heinemann, Woburn, MA1999
• Pearls of Wisdom 
  Chapter: Spinal cord disease. 
  Ougorets I, Ruff RL, Kaminski HJEditors: Labanowski MJ.Boston Medical Publishing1998
• Handbook of Clinical Neurology 
  Chapter: Metastatic epidural spinal cord compression. 
  Lada R, Kaminski HJ, Ruff RLEditors: Vinken PJ, Bruyn GW.Elsevier NV, Amsterdam, Netherlands1997
• Office Practice of Neurology 
  Chapter: Endocrine, nutritional and drug-induced myopathies. 
  Sunshine JJ, Kaminski HJ, Ruff RLEditors: Samuels MA, Feske S.Churchill Livingstone, New York, NY1996
• The Molecular Biology of Membrane Transport Disorders. 
  Chapter: The myasthenic syndromes. 
  Kaminski HJ, Ruff RLEditors: Schultz SG, Andreoli TE, Brown, AM, Fambroughm DM, Hoffman JF, Welsh MJ.Plenum Publishing Co, New York, NY1996
• Join now to see all

Abstracts/Posters

• Myasthenia Gravis Patient Registry: Significant Knowledge Gap in Understanding Disease Diagnosis and Treatment.
  Salame KG, Kaminski HJ, Cutter GR, Feese M, Aly R, American Academy of Neurology, Vancouver, BC, Canada, 1/1/2016
• Thymectomy in Non-thymomatous Myasthenia Gravis Patients on Prednisone: Results from MGTX, a Randomized, Controlled Trial.
  Wolfe GI, Kaminski HJ, Inmaculada B. Aban IB, Minisman G. Hui-Chien Kuo H-CCutter GR, MGTX Study Group, American Academy of Neurology, 1/1/2016
• Randomized trial of thymectomy in myasthenia gravis. Correspondence.
  Wolfe GI, Kaminski HJ, Sonnett JR, Aban IB, Kuo H-C, Cutter GR, J Thorac Dise, 1/1/2016
• A Sad State of Affairs. Editorial. Foundation Focus.
  Kaminski HJ, Schulhof S, Myasthenia Gravis Foundation of America, 1/1/2015
• Development of the Myasthenia Gravis Patient Registry of the MG Foundation of America.
  Kaminski HJ, Burns T, Minisman G, Cutter GC, Myasthenia Gravis, Paris, France, 1/2/2013
• Survivin As a Therapeutic Target: One Rare Disorder Learning from Another.
  Kusner LL, Kaminski HJ, Ciesielski M, Fenstermaker R, NORD, 1/1/2013
• Myasthenia Gravis Patient Registry of the MG Foundation of America
  Kaminski HJ, Burns T, Minisman G, Cutter GC, NORD, Myasthenia Gravis Foundation of America, 1/1/2013
• MGTX: update on the thymectomy trial in non-thymomatous myasthenia gravis.
  Wolfe GI, Cutter GR, Kaminski HJ, Jaretzki III A, Minisman G, Aban I, Conwit R, 12th International Conference on Myasthenia Gravis and Related Disorders, 1/23/2012
• Coversin, a complement inhibitor, Ready for Phase 2 evaluation for myasthenia gravis and beyond.
  Kaminski HJ, Weston-Davies W, Benatar M, Kusner L, Neurotherapeutics, 1/1/2012
• Establishment of the MGFA patient registry.
  Kaminski HJ, Cutter G, Benatar M, Burns T, Sanders D, Wolfe G, Muscle Nerve, 1/1/2011
• Feasibility of specific targeting of treatment to the junction.
  Kusner LL, Satijia N, Richards MJ, Kaminski HJ, Muscle Nerve, 1/1/2011
• Complement ablation moderates disease in the muscular dystrophy mouse with myositis.
  Kaminski HJ, Kusner L, Soltys J, Zhou Y, Parulkar S, Lai W, Cheng G, Mol Immunol, 1/1/2008
• Novel complement inhibitor (rEV576) ameliorates EAMG.
  Soltys J, Kusner L, Young A, et al, Ann NY Acad Sci, 1/1/2007
• Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
  Sanders DB, Aarli JA, Cutter GR, Jaretzki A, 3rd, Kaminski HJ, Phillips LH, 2nd, Neurology, 1/1/2006
• Decay accelerating factor has greater protective role than CD59 in experimental autoimmune myasthenia gravis.
  Kaminski HJ, Richmonds C, Lin F, Medof E, Invest Ophthalmol Vis Sci, 1/1/2004
• Prospective Survey of NANOS and MGFA Members on Treatment of Ocular Myasthenia Gravis.
  Kupersmith MJ, Kaminski HJ, Invest Ophthalmol Vis Sci, 1/1/2004
• Preoperative preparation of patients with myasthenia gravis forestalls postoperative respiratory complications after thymectomy.
  Jaretzki A, Aarli JA, Kaminski HJ, Phillips LH, Sanders DB, Ann Thorac Surg, 1/1/2003
• Anti-titin antibodies are not associated with a specific thymoma histology.
  Voltz R, Albrich W, Kirchner T, Nagel D, Wick M, Sommer N, Illa I, Kaminski H, Schumm F, Hohlfeld R, J Neurol Neurosurg Psychiatry, 1/1/2003
• A tribute to Joseph Foley
  Kaminski HJ, Leigh RJ, Neurology, 1/1/2003
• Problems in the evaluation of thymectomy for myasthenia gravis.
  Jaretzki A, 3rd, Kaminski HJ, Phillips LH, 2nd, Sanders DB, Ann Thorac Surg, 1/1/2002
• Nitric Oxide and cGMP Modulation of Extraocular Muscle Contraction.
  Kaminski HJ, Richmonds CR, Ann NY Acad Sci, 1/1/2002
• Extraocular Muscle Fatigue.
  Kaminski HJ, Richmonds C, Ann NY Acad Sci, 1/1/2002
• Mice Deficient in decay accelerating factor are particularly susceptible to experimental autoimmune myasthenia gravis.
  Kaminski HJ, Lin F, Richmonds C, Medof ME, Ann New, 1/1/2002
• Predictors of mechanical ventilation in patients with myasthenia gravis exacerbation.
  Suarez JI, Boonyapisit K, Zaidat OO, Kaminski HJ, Ruff RL, J Neurol Sci, 1/1/2001
• Gene expression profile of extraocular muscle phenotype.
  Porter JD, Merriam AP, Andrade FH, Richmonds C, Khanna S, Kaminski HJ, Invest Ophthalmol Vis Sci, 1/1/2001
• Join now to see all

Lectures

• Thymectomy As Treatment for Myasthenia Gravis: Clinical and Biological Aspects 
  Case Western Reserve University, Cleveland, OH - 1/20/2016
• Ancillary Study Opportunities from MGTX 
  Oxford, UK - 1/9/2016
• Development and Birth of MGTX 
  Oxford, UK - 1/8/2016
• Thymectomy for Myasthenia Gravis: Clinical and Biological Aspects 
  Bethesda, MD - 1/5/2016
• Thymectomy for Myasthenia Gravis, Finally a Justification 
  SUNY Downstate, Brooklyn, NY, 2016; Uniformed Services University for the Health Sciences, Bethesda, - 1/4/2016
• Thymectomy and Myasthenia Gravis 
  Raleigh, NC - 1/2/2016
• Shared Pathogenic Mechanisms of Cancer and Autoimmunity. 
  Georgetown University, Washington, DC - 1/20/2015
• How Clinical Trials of Myasthenia Gravis Can Inform Preclinical Drug Development. 
  National Institutes of Health, Bethesda, MD - 1/25/2014
• Biomarker Development for Myasthenia Gravis. 
  Tokyo, Japan - 1/30/2013
• Myasthenia Gravis Treatment and Development of Novel Therapies. 
  Children's National Medical Center, Washington, DC - 1/18/2013
• Establishment of the Myasthenia Gravis Patient Registry 
  Miami, FL - 1/9/2013
• Development of the Patient-Driven Myasthenia Gravis Patient Registry 
  Bethesda, MD - 1/6/2013
• The Future of Neurology 
  George Washington University, Washington, DC - 1/2/2013
• Immigration 
  Washington International School, Washington, DC - 1/1/2013
• Discussant, Translational Research Across the Continuum. 
  Washington, DC - 1/28/2012
• Coversin, a Complement Inhibitor, Ready for Phase 2 Evaluation for Myasthenia Gravis and Beyond. 
  Washington, DC - 1/24/2012
• Biomarkers for Myasthenia Gravis 
  New York, NY - 1/21/2012
• What Eye Muscles Can Teach Us about Neuromuscular Disorders 
  Case Western Reserve University, Cleveland, OH - 1/18/2012
• Challenging Cases: Myasthenia Gravis. 
  Washington, DC - 1/11/2012
• Myasthenia gravis: Autoimmune Targets in Extraocular Muscle. 
  Fort Lauderdale, FL - 1/9/2012
• Pharma Influence on Physicians 
  George Washington University, Washington, DC - 1/5/2012
• Neurology Resident Demographics: Fewer International Trainees? 
  San Diego, CA - 1/25/2011
• Establishment of the MGFA Patient Registry. 
  San Francisco, CA - 1/14/2011
• The Role of Patient Registries in Research. 
  1/13/2011
• Why Are Extraocular Muscles Preferentially Involved by Myasthenia Gravis, and Why You May Care? 
  George Washington University, Washington, DC - 1/10/2011
• Join now to see all

Other

• Thymectomy study results. 
  Wolfe GI, Kaminski HJ, Aban I, Cutter GR, Foundation Focus, Myasthenia Gravis Foundation of America national newsletter
  1/1/2016
• Communication with your doctor. 
  Kusner LL, Kaminski HJ, Ohio MG Chapter Newsletter
  1/1/1996
• Gazpacho 
  Kaminski HJ, MGFA Recipes, Published by the Myasthenia Gravis Foundation of America
• Preface 
  Kaminski HJ, Neurology Oral Boards Review, Humana Press
  Totowa, NJ
• Myasthenia Gravis. 
  Kaminski HJ, NORD
  https://rarediseases.org/rare-diseases/myasthenia-gravis/
• Proceedings of the International Symposium for Therapy of Ocular Motility and Related Visual Disturbances. 
  Kaminski HJ, Leigh RJ
  http://129.22.80.67/dept/neurology/ocular.html
• Myopathies associated with parathyroid disorders. 
  Lindberg J, Kaminski HJ, Medlink Neurology
  www.medlink.com
• Drug-induced myasthenic syndromes. 
  Koontz D, Kaminski HJ, Medlink Neurology
  www.medlink.com
• Join now to see all